Cerebrovascular disease: use of fluorodeoxyglucose.
Herholz
K
K
Max-Planck-Institut für Neurologische Forschung, Universität zu Köln, Federal Republic of Germany.
Heiss
W D
WD
D002545:Brain Ischemia / Q000175:diagnosis; D002544:Cerebral Infarction / Q000175:diagnosis / Q000188:drug therapy; D002561:Cerebrovascular Disorders / Q000000981:diagnostic imaging*; D003837:Deoxy Sugars; D003847:Deoxyglucose / Q000031:analogs & derivatives; D019788:Fluorodeoxyglucose F18; D006801:Humans; D002546:Ischemic Attack, Transient / Q000175:diagnosis; D008279:Magnetic Resonance Imaging; D012016:Reference Values; D014055:Tomography, Emission-Computed; D014057:Tomography, X-Ray Computed
D003837:Deoxy Sugars; D019788:Fluorodeoxyglucose F18; D003847:Deoxyglucose